US equities
|
NVDA
$233.95
▲+1.34%
MU
$1,074.89
▼-2.05%
TSLA
$370.59
▲+4.65%
SPCX
$158.96
▲+7.35%
SNDK
$1,719.99
▼-3.79%
AMD
$633.91
▲+2.95%
STX
$848.99
▼-10.21%
INTC
$119.33
▼-0.56%
NVDA
$233.95
▲+1.34%
MU
$1,074.89
▼-2.05%
TSLA
$370.59
▲+4.65%
SPCX
$158.96
▲+7.35%
SNDK
$1,719.99
▼-3.79%
AMD
$633.91
▲+2.95%
STX
$848.99
▼-10.21%
INTC
$119.33
▼-0.56%
FinancialContent
Sign in
Markets
Overview
News
World markets
Treasuries
Currencies
Commodities
Economy
Stocks
Overview
Most active
Gainers
Losers
Largest companies
52-week gainers
52-week losers
ETFs
Overview
Popular funds
Most active
Gainers
Losers
News
Research
Search
Sectors
ProKidney Corp. - Class A Ordinary Shares
(NQ:
PROK
)
1.720
+0.010 (+0.58%)
Delayed Quote
Updated: 4:00 PM EDT, Oct 2, 2026
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about ProKidney Corp. - Class A Ordinary Shares
< Previous
1
2
3
4
5
6
Next >
ProKidney Reports Statistically and Clinically Significant Topline Results for the Phase 2 REGEN-007 Trial Evaluating Rilparencel in Patients with Chronic Kidney Disease and Diabetes
July 08, 2025
From
ProKidney
Via
GlobeNewswire
Which stocks are moving after the closing bell on Friday?
↗
July 04, 2025
The US market regular session of Friday is over, let's have a look at the top gainers and losers in the after hours session today.
Via
Chartmill
12 Health Care Stocks Moving In Thursday's After-Market Session
↗
July 03, 2025
Via
Benzinga
PROK Stock Earnings: ProKidney Beats EPS for Q2 2024
↗
August 09, 2024
PROK stock results show that ProKidney beat analyst estimates for earnings per share the second quarter of 2024.
Via
InvestorPlace
PROK Stock Earnings: ProKidney Reported Results for Q4 2023
↗
June 27, 2024
ProKidney just reported results for the fourth quarter of 2023.
Via
InvestorPlace
Top movers in Thursday's after hours session
↗
July 03, 2025
Wondering what's happening in today's after-hours session? Stay tuned for the latest updates on stock movements.
Via
Chartmill
ProKidney Corp. Completes Domestication from the Cayman Islands to Delaware
July 01, 2025
From
ProKidney
Via
GlobeNewswire
This CorMedix Analyst Is No Longer Bullish; Here Are Top 3 Downgrades For Monday
↗
June 30, 2025
Via
Benzinga
Let's have a look at the top gainers and losers one hour before the close of the markets of today's session.
↗
June 25, 2025
Here are the top movers in Wednesday's session, showcasing the stocks with significant price changes.
Via
Chartmill
What's going on in today's after hours session
↗
June 20, 2025
Let's have a look at what is happening on the US markets after the closing bell on Friday. Below you can find the top gainers and losers in today's after hours session.
Via
Chartmill
12 Health Care Stocks Moving In Wednesday's After-Market Session
↗
June 18, 2025
Via
Benzinga
ProKidney Reports First Quarter 2025 Financial Results and Business Highlights
May 12, 2025
From
ProKidney
Via
GlobeNewswire
ProKidney Reports Full Year 2024 Financial Results and Business Highlights
March 17, 2025
From
ProKidney
Via
GlobeNewswire
Top 3 Health Care Stocks You'll Regret Missing This Quarter
↗
March 13, 2025
Via
Benzinga
ProKidney to Present at the 43rd Annual J.P. Morgan Healthcare Conference
January 07, 2025
From
ProKidney
Via
GlobeNewswire
ProKidney to Participate in Two Upcoming Conferences: Evercore HealthCONx Conference and the Citi Global Healthcare Conference
November 26, 2024
From
ProKidney
Via
GlobeNewswire
ProKidney Reports Third Quarter 2024 Financial Results along with Regulatory and Clinical Development Updates Following Successful FDA Type B Meeting
November 12, 2024
From
ProKidney
Via
GlobeNewswire
ProKidney to Participate in the Guggenheim Inaugural Healthcare Innovation Conference and the Jefferies London Healthcare Conference
November 05, 2024
From
ProKidney
Via
GlobeNewswire
ProKidney Announces Five Abstracts Selected for Presentation at the American Society of Nephrology’s Kidney Week 2024
October 14, 2024
From
ProKidney
Via
GlobeNewswire
ProKidney to Participate in the UBS Virtual Organ Restoration Day
October 09, 2024
From
ProKidney
Via
GlobeNewswire
ProKidney Announces Strategic Updates to its Phase 3 Program to Accelerate Rilparencel’s Registrational Path to Potential Approval in the U.S.
September 03, 2024
From
ProKidney
Via
GlobeNewswire
ProKidney to Participate in the Morgan Stanley 22nd Annual Global Healthcare Conference
August 27, 2024
From
ProKidney
Via
GlobeNewswire
ProKidney Reports Business Updates and Second Quarter 2024 Financial Results
August 09, 2024
From
ProKidney
Via
GlobeNewswire
Over $30M Bet On This Energy Stock? Check Out These 3 Stocks Insiders Are Buying
↗
June 26, 2024
Via
Benzinga
ProKidney Announces the Closing of $140 Million Public Offering of Class A Ordinary Shares and Concurrent Registered Direct Offering, Including Exercise of Underwriters’ Option
June 17, 2024
From
ProKidney
Via
GlobeNewswire
ProKidney Announces Pricing of its Upsized $130 Million Public Offering of Class A Ordinary Shares and Concurrent Registered Direct Offering
June 11, 2024
From
ProKidney
Via
GlobeNewswire
Why Contango Ore Shares Are Trading Lower By 18%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session
↗
June 11, 2024
Via
Benzinga
12 Health Care Stocks Moving In Tuesday's Intraday Session
↗
June 11, 2024
Via
Benzinga
Why Calavo Growers Shares Are Trading Higher By 12%; Here Are 20 Stocks Moving Premarket
↗
June 11, 2024
Via
Benzinga
12 Health Care Stocks Moving In Tuesday's Pre-Market Session
↗
June 11, 2024
Via
Benzinga
< Previous
1
2
3
4
5
6
Next >
